+

ZA976725B - Novel pentapeptides as antitumor agents - Google Patents

Novel pentapeptides as antitumor agents

Info

Publication number
ZA976725B
ZA976725B ZA976725A ZA976725A ZA976725B ZA 976725 B ZA976725 B ZA 976725B ZA 976725 A ZA976725 A ZA 976725A ZA 976725 A ZA976725 A ZA 976725A ZA 976725 B ZA976725 B ZA 976725B
Authority
ZA
South Africa
Prior art keywords
antitumor agents
pentapeptides
novel
novel pentapeptides
antitumor
Prior art date
Application number
ZA976725A
Other languages
English (en)
Inventor
Teresa Barlozzari
Andreas Haupt
Christian Griesinger
Bernd Janssen
Daniel Belik
Michael Boretzky
George R Pettit
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA976725B publication Critical patent/ZA976725B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA976725A 1996-07-30 1997-07-29 Novel pentapeptides as antitumor agents ZA976725B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/688,334 US5741892A (en) 1996-07-30 1996-07-30 Pentapeptides as antitumor agents

Publications (1)

Publication Number Publication Date
ZA976725B true ZA976725B (en) 1999-02-12

Family

ID=24764016

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976725A ZA976725B (en) 1996-07-30 1997-07-29 Novel pentapeptides as antitumor agents

Country Status (7)

Country Link
US (1) US5741892A (xx)
EP (1) EP0915908A1 (xx)
JP (1) JP2000516923A (xx)
AU (1) AU3769297A (xx)
TW (1) TW472063B (xx)
WO (1) WO1998004581A1 (xx)
ZA (1) ZA976725B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033212A1 (fr) * 1995-04-21 1996-10-24 Teikoku Hormone Mfg. Co., Ltd. Nouveaux derives peptidiques
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7256257B2 (en) 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
EP1545613B9 (en) * 2002-07-31 2012-01-25 Seattle Genetics, Inc. Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
SG195524A1 (en) 2003-11-06 2013-12-30 Seattle Genetics Inc Monomethylvaline compounds capable of conjugation to ligands
RU2254139C1 (ru) * 2003-11-14 2005-06-20 Российский онкологический научный центр им. Н.Н. Блохина РАМН Средство, обладающее противоопухолевым действием
US7853332B2 (en) * 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Birドメイン結合化合物
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
ES2528922T3 (es) 2007-07-16 2015-02-13 Genentech, Inc. Anticuerpos anti-CD79b humanizados e inmunoconjugados y métodos de uso
ES2579323T3 (es) 2007-07-16 2016-08-09 Genentech, Inc. Anticuerpos anti-CD79B e inmunoconjugados y métodos de uso
AR070168A1 (es) 2008-01-31 2010-03-17 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados y metodos de uso de los mismos
SG10201501095WA (en) 2010-02-12 2015-04-29 Pharmascience Inc Iap bir domain binding compounds
JP6133431B2 (ja) 2012-11-24 2017-05-24 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. 親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. 荷電連結体及び共役体のためのその使用
BR112017023576A2 (pt) 2014-09-23 2023-10-03 Genentech Inc Método para tratar uma disfunção proliferativa de células b
CN113350518A (zh) 2015-07-12 2021-09-07 杭州多禧生物科技有限公司 与细胞结合分子的共轭偶联的桥连接体
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN116897539A (zh) * 2021-03-10 2023-10-17 日本电信电话株式会社 信息处理装置、分析方法和程序
EP4400121A1 (en) 2021-09-03 2024-07-17 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
SG87056A1 (en) * 1991-08-09 2002-03-19 Teikoku Hormone Mfg Co Ltd Novel tetrapeptide derivative
CA2136339C (en) * 1992-05-20 2008-02-05 Andreas Haupt Derivatives of dolastatin
ATE196296T1 (de) * 1992-12-16 2000-09-15 Basf Ag Dolastatin analog
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides

Also Published As

Publication number Publication date
WO1998004581A1 (en) 1998-02-05
AU3769297A (en) 1998-02-20
EP0915908A1 (en) 1999-05-19
US5741892A (en) 1998-04-21
JP2000516923A (ja) 2000-12-19
TW472063B (en) 2002-01-11

Similar Documents

Publication Publication Date Title
ZA976725B (en) Novel pentapeptides as antitumor agents
EP0914330A4 (en) NEW TYPE COMPOUNDS
EP0904104A4 (en) NEW CONNECTIONS
GB9601067D0 (en) Novel compounds
SG60040A1 (en) Novel heterroaryl-oxazolidinones
EP0907375A4 (en) NEW COMPOUNDS
AP9901465A0 (en) Illudin analogs useful as antitumor agents
AP9701047A0 (en) Novel compounds
ZA976724B (en) Novel tetrapeptides as antitumor agents
GB9600955D0 (en) Novel compounds
EP0895545A4 (en) A NEW PROTEIN, TRAF 6
AP9701037A0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
EP0954525A4 (en) NEW CONNECTIONS
GB2310039B (en) Turbulence-noise cancelling means
PL328019A1 (en) Novel phenantidines
GB9601068D0 (en) Novel compounds
EP0907377A4 (en) NEW CONNECTIONS
AU134224S (en) Cabriolet
GB9601099D0 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9608813D0 (en) Pyridinyl-2-cyclopenten-1-ones as selctive cyclooxygenase-2-inhibitors
GB9601271D0 (en) Novel uses
AU127914S (en) Z bracket
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载